Windlas Biotech is a major CDMO in the pharmaceutical industry. It is currently trading around 740 with ROE 0f 13.7%.
Biocon is India's top biotech business, noted for its significant presence. Its share price is around 357 and ROE at 5.47%.
SPARC, trading at 1522 with ROE of 16.7%, specializes in the development of novel therapies for cancer and mental illnesses.
Lupin, trading at 1633 with ROE of 14.3%, is a key participant in the pharmaceutical and biotechnology industries.
Syngene is a major contract research business that is currently trading at 714 and has a ROE of 13.2%.